plasma showed a minimal reduction on days 11 to 14 after GnRH antagonist treatment on day 4, although this was significant (P < 005) only on days 11 and 13. There was no effect of treatment on day 11 on daily pro¬ gesterone concentration, and the timing of luteolysis and the duration of corpus luteum function was unaffected by GnRH antagonist treatment on either day 4 or day 11. These results indicate that the episodic secretion of progesterone during the luteal phase of the oestrous cycle in ewes is independent of LH pulses and normal progesterone secretion by the corpus luteum can be maintained with minimal basal concentrations of LH.
Introduction
Although corpus luteum function in terms of progesterone secretion is highly dependent on pulsatile luteinizing hormone (LH) secretion in primates (Fraser et ai, 1986) , the situation in sheep is not clear. Total removal of LH by hypophysectomy (Kaltenbach et ai, 1968; Karsch et ai, 1971) or immunoneutralization (Fuller & Hansel, 1970) results in regression of the corpus luteum in ewes, which can be prevented by treatment with LH (Kaltenbach et ai, 1968; Karsch et ai, 1971) . Although LH receptors are present on both the large and small progesterone-secreting cells which comprise about 50% of the cells in the sheep corpus luteum (Rodgers et ai, 1984) , LH stimulates progesterone release only from the small cells. The large cells secrete greater amounts of progesterone than small cells under basal conditions and appear to contribute most of the progesterone secreted by the sheep corpus luteum (Alila & Dowd, 1991; Wiltbank et ai, 1991) .
We observed pulsatile secretion of progesterone, independent of LH pulses, during the late luteal phase of the cycle (McNeilly & Fraser, 1987) . This was subsequently confirmed and related to a pulsatile or episodic secretion of progesterone by the corpus luteum into the ovarian vein in ewes (Alecozay et ai, 1988) . We also showed that pulsatile progesterone secretion continued at the end of the luteal phase when pulsatile secretion of LH had been abolished by chronic treatment of ewes with a gonadotrophin-releasing hormone (GnRH) agonist throughout the luteal phase (McNeilly & Fraser, 1987) (Horvath et ai, 1982) .
The eighteen ewes were divided at random into three groups of six ewes. Group 1 ewes were treated with GnRH antagonist on day 4 and group 2 ewes on day 11 of the luteal phase. Group 3 ewes were given an i.m. injection of sterile water on days 4 and 11 and acted as controls for both treatment groups.
Blood samples (7 ml) were taken every day from the jugular vein at 09:00-11:00 h from each ewe starting on day 0 (oestrus) and continuing for 22 days afterwards. In addition, serial blood samples (3 ml) were taken at 15 min intervals for 12 h on day 4 from group 1 and 3 ewes and on day 11 from group 2 and 3 ewes after GnRH antagonist injection at 09:00 h. Serial blood samples (3 ml) were then taken at 10 min intervals for 8 h from group 1 and 2 ewes between 24 and 32 h after GnRH antagonist treatment and from groups 1, 2 and 3 ewes between 48 and 56 h after GnRH antagonist treatment. All serial blood samples were collected through a jugular vein cannula inserted 16 h before the first sampling period in each group.
All plasma samples were assayed for LH and progesterone and all daily and hourly samples through all serial sampling periods were assayed for FSH.
Radioimmunoassays
The concentrations of FSH (McNeilly et ai, 1976) , LH (McNeilly et ai, 1986 ) and progesterone (McNeilly & Fraser, 1987) in plasma were measured in duplicate using radioimmunoassays described previously and results expressed in terms of ng NIH-FSH-S13 ml"1, ng NIH-LH-S18 ml"1 or ng progesterone ml"1 (Sigma, UK). Assay sensitivities were 4, 0-2 and 01 ng ml"1 for FSH, LH and progesterone, respectively, with intra-and interassay coefficients of variation of 7% and 11% for FSH, 6% and 9% for LH and 8% and 10% for progesterone.
Statistical analysis
No statistical comparisons were made between the ewes treated with GnRH antagonist on days 4 (group 1) or day 11 (group 2) but each was compared with the control group (group 3) separately. Plasma concentrations of LH, FSH and progesterone in daily samples were compared using analysis of variance followed by Newman Keul's test where appropriate. Luteolysis was defined as starting when a sustained drop in plasma concentrations of progesterone occurred leading to plasma concentrations below 0-6 ng ml " '. In serial sampling periods, the characteristics of the LH and progesterone profiles were assessed using the Munro pulse analysis program (Elsevier-Biosoft, (Fig. ld-f ). Oestrus was delayed in all treated ewes until at least day 22, the end of the experiment, 10 days after GnRH antagonist treatment, whereas in control ewes oestrus occurred within 2 days of the onset of luteolysis, assessed by the decline in plasma progesterone. Plasma concentrations of LH were significantly (P<001) increased compared with those in treated ewes on days 4 and 5 after GnRH antagonist treatment (Fig. Id) ; this increase co-incided with the onset of oestrus in the control ewes and hence represented the preovulatory LH surge.
Concentrations of FSH and pulsatile release of LH and progesterone Day 4. There was no significant effect of treatment with GnRH antagonist on day 4 on plasma concentration of FSH, although concentrations tended to be higher after treatment (Table 1) . Representative profiles of the pulsatile secretion of LH and progesterone for two control and two treated ewes on day 6, 2 days after GnRH antagonist treatment (Fig. 2) , and the overall analysis of basal and pulsatile secretion (Table 1) are shown. GnRH antagonist treatment resulted in a significant (P < 005) suppression of basal concentrations of LH (Table 1) and totally abolished the pulsatile secretion of LH for at least 3 days after treatment ( Fig. 2; Table 1 ). No pulses of LH occurred in treated ewes from the time of GnRH antagonist injection. In contrast, GnRH antagon¬ ist treatment had no effect on the basal concentration or the pulsatile release of progesterone (Table 1) .
Day 11. There was no effect of GnRH antagonist treatment on the overall plasma concentration of FSH (Table 2, Fig. 1 ). In contrast, GnRH antagonist treatment resulted in the immediate and sustained suppression of the overall mean plasma concentrations of LH (P < 005 compared with control) and abolished the pulsatile secretion of LH ( Fig. 3; Table 2 ) in comparison with that of control animals. In contrast, there was no effect of GnRH antagonist treatment on the parameters of pulsatile secretion of progesterone for at least 3 days after GnRH antagonist treatment on day 11 ( Fig. 3 ; Table 2 ). 
Relationship between LH and progesterone pulses
Results from the serial sampling periods in control ewes on days 4, 6, 11 and 13 of the luteal phase were combined around the start of all LH pulses occurring in all control ewes on each of these days so that any relationship between the pulsatile secretion of LH and changes in the plasma concentrations of progesterone could be determined. The results (Fig. 4) abolition of the pulsatile release of LH by treating ewes with a GnRH antagonist had no effect on episodic progesterone secretion during the early luteal phase between days 3 and 6 and the late luteal phase between days 11 and 13. In terms of overall daily progesterone secretion, there was no effect of treatment on day 11, but after treatment on day 4 plasma concentrations of progesterone were lower between days 11 and 14, although these were significant only on days 11 and 13. Thus it appears that LH pulses play at most only a minimal role in maintaining progesterone secretion by the corpus luteum in ewes.
Previous studies have confirmed that the sheep corpus luteum requires LH to maintain progesterone secretion (Kaltenbach et ai, 1968; Karsch et ai, 1971 ). The present results do not contradict this since the treatment with GnRH antagonist, although abolishing pulsatile LH (FSH) and progesterone in plasma, and pulse frequency and pulse amplitude for LH and progesterone on days 4 and 6 of the luteal phase in control ewes (n = 6) and on days 4, 5 and 6 in ewes (n = 6) treated on day 4 of the luteal phase with a gonadotrophin-releasing hormone (GnRH) antagonist at the start of the sampling period (ngml"1) (Niswender et ai, 1976) and LH stimulates the release of progesterone from small luteal cells in vitro (Fitz et ai, 1982; Wiltbank et ai, 1991 Plasma concentrations of FSH were greater in treated than in control ewes after GnRHantagonist treatment on day 4 probably owing to the reduction in ovarian steroid and inhibin secretion that probably followed the suppression of pulsatile LH secretion (Campbell et ai, 1990) . However, it is unlikely that FSH is involved in the control of progesterone secretion by the sheep corpus luteum since FSH receptors have not been identified on the corpus luteum (Alila & Dowd, 1991) and suppression of plasma concentrations of FSH throughout the luteal phase by treatment with bovine follicular fluid did not affect plasma concentrations of progesterone (Wallace & McNeilly, 1985; Brooks et ai, 1992) . The cause of the episodic release of progesterone is unknown. Alterations in blood flow in the ovarian vein do not appear to be involved (Collett et ai, 1973; Alecozay et ai, 1988; Campbell et ai, 1990) . Whereas there are between 10 and 20 times the number of small LH-responsive than (Alila & Dowd, 1991; Wiltbank et ai, 1991 Time relative to onset of LH pulse (min) Fig. 4 . Changes in the mean ( + sem) plasma concentrations of (a) LH and (b) progesterone centred around spontaneous pulses of LH on days 4 (n = 13 pulses), 6 (n = 14 pulses), 11 (n = 16 pulses) and 13 (n = 14 pulses) of the luteal phase in control ewes.
indicated by the delay in the onset of oestrus for at least 7 days after GnRH antagonist treatment on day 11. This suggests that ovarian follicle components may play only a minor role in the oxytocin mediated control of prostaglandin-induced luteolysis (Flint et ai, 1990; Silvia et ai, 1991 (Fraser et ai, 1986 ).
